217 results on '"Schilling, Daniela"'
Search Results
2. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.
3. In-vivo X-ray dark-field computed tomography for the detection of radiation-induced lung damage in mice
4. Early detection of radiation-induced lung damage with X-ray dark-field radiography in mice
5. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer
6. Selenium does not affect radiosensitivity of breast cancer cell lines
7. 2788: Characterization of radiosensitization by kinase inhibition in preclinical pancreatic cancer models
8. 2557: Radiosensitization of glioblastoma by BET (Bromodomain and Extra-Terminal motif) inhibition
9. 642: Characterization of radiation response of pancreatic tumor cells in correlation with MYC expression
10. Establishment of a 3D Model to Characterize the Radioresponse of Patient-Derived Glioblastoma Cells
11. Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain Metastases
12. The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition
13. Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines
14. Figure S5 from The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo
15. Data from The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo
16. Table S1 from The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo
17. The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation
18. Sensitizing tumor cells to radiation by targeting the heat shock response
19. A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells
20. Validation of Heat Shock Protein 70 as a Tumor-Specific Biomarker for Monitoring the Outcome of Radiation Therapy in Tumor Mouse Models
21. Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells
22. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA
23. X-ray Dark-Field CT for Early Detection of Radiation-induced Lung Injury in a Murine Model
24. Compositional Hazard Analysis of UML Component and Deployment Models
25. Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levels
26. Monitoring PAI-1 and VEGF Levels in 6 Human Squamous Cell Carcinoma Xenografts During Fractionated Irradiation
27. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells
28. Irradiation-Induced Regulation of Plasminogen Activator Inhibitor Type-1 and Vascular Endothelial Growth Factor in Six Human Squamous Cell Carcinoma Lines of the Head and Neck
29. Histopathological Tumor and Normal Tissue Responses after 3D-Planned Arc Radiotherapy in an Orthotopic Xenograft Mouse Model of Human Pancreatic Cancer
30. Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines
31. Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer
32. PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck
33. The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing CancerIn VitroandIn Vivo
34. Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma
35. The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer
36. Differential inhibition of inducible T cell cytokine secretion by potent iron chelators
37. Early detection of radiation-induced lung damage with X-ray dark-field radiography in mice
38. Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic Analysis of Pancreatic Cancer Cells
39. Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma
40. Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma
41. Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922
42. Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922
43. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines
44. Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine
45. ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS
46. A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16).
47. A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer
48. A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16).
49. Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck
50. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.